VisualMED Will Provide Clinical Workflow Engine for Phase II Clinical Trials
December 08 2011 - 7:22AM
Marketwired
VisualMED Clinical Solutions Corp. (The "Company") (PINKSHEETS:
VMCS) (FRANKFURT: VA6) announces it will be providing structured
medical content to a provider of software integration services
serving major drug developers. The latter seek new forms of
standardization designed to both reduce cost and save precious time
to market. The use of standardized clinical workflow engine and
analysis should have a positive impact in moving forward phase II
clinical trials.
The deal is worth $2 M over 2 years for the company and involves
mostly formatting and delivery of existing applications and rich
medical content. It provides the Company with unprecedented
opportunities to sell limited clinical information, a more flexible
business model with shorter sale cycle.
"Drug companies are slowly coming around to using solutions that
keep pace with the complexities involved in collating information,
as we understand more about illnesses and the variable effects of
treatment," says Chairman Gerard Dab. "VisualMED has been offering
drug companies advanced tools such as one of the industry's best
inference engines, medical content and clinical workflow management
systems."
The Company intends to offer reduced fixed-term 3rd party
licensing at extremely competitive rates for these types of
offerings and will determine the appropriate value of this
particular solution as it becomes clear how much time and money the
pharmaceutical industry can save, in an environment where every day
counts against future revenues due to patent limitation.
ABOUT VISUALMED
VisualMED markets smart Clinical Information Systems (CIS) with
EHR and Computerized Physician Order Entry that are at the core of
the new regulatory environment ushered in by the American Recovery
and Reinvestment Act of 2009 and the Health Reform Act of 2010. We
offer medical facilities and physicians a broad array of clinical
applications with rich embedded clinical data, both scalable and
interoperable, and whose high level of usability has been tested by
over one thousand clinicians over many years in tertiary care and
ambulatory environments. Our solutions help medical facilities
increase provider efficiency, bring down operating costs,
demonstrate meaningful use for ARRA grants and subsidies, and
reduce mortality and morbidity. The Company's Suites of Medical
Solutions operate on state of the art proprietary software
platforms with advanced analytical capabilities provided by Visual
Healthcare Corp. (PINKSHEETS: VSHC).
Detailed information on our company and its products is
available on our web site at www.visualmedsolutions.com
FORWARD-LOOKING STATEMENTS Except for historical information
provided herein, this press release may contain information and
statements of a forward-looking nature concerning the future
performance of the Company. These statements are based on
suppositions and uncertainties as well as on management's best
possible evaluation of future events. Such factors may include,
without excluding other considerations, fluctuations in quarterly
results, evolution in customer demand for the Company's products
and services, the impact of price pressures exerted by competitors,
and general market trends or economic changes. As a result, readers
are advised that actual results may differ from expected
results.
For further information, please contact: Gerard Dab
514-582-5220